Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
NCT ID:
NCT02398656
Group ID:
EG000
Title:
Tenecteplase (tNK)
Description:
Experimental: TNK-tPA (0.25mg/kg) given as a single, intravenous bolus immediately upon randomization. Experimental treatment will be administered as a single intravenous bolus over 1-2 minutes as per the standard manufacturers' instructions for use. Tenecteplase, a genetically engineered mutant tissue plasminogen activator, has a longer half-life, is more fibrin specific, produces less systemic depletion of circulating fibrinogen, and is more resistant to plasminogen activator inhibitor than alteplase.
Tenecteplase: TNK will be administered as a single intravenous bolus over 1-2 minutes within 90 minutes of the CT scan.
Deaths Number Affected:
20
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
432
Other Number Affected:
35
Other Number At Risk:
435
Study:
NCT02398656
Results Section:
NCT02398656
Adverse Events Module:
NCT02398656